NERV
Minerva Neurosciences Inc
Halal Rating :
Last Price
$2.19
Last updated:
Market Cap
-
7D Change
3.3%
1 Year Change
-71.63%
Company Overview
Industries
Exchange
Next Earnings Date
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for the treatment of central nervous system (CNS) diseases. The company's primary product candidate is roluperidone, which is being developed for the treatment of negative symptoms in patients with schizophrenia.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Minerva Neurosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.